Expert Ratings For Medpace Hldgs
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Medpace Holdings (NASDAQ:MEDP) in the latest quarter, with 3 bullish and 1 somewhat bullish ratings. The average 12-month price target is $447.0, a 2.83% decline from the prior average. Key analysts have adjusted their ratings and price targets, reflecting their responses to market dynamics and company performance.
July 24, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed ratings for Medpace Holdings, with 3 bullish and 1 somewhat bullish ratings. The average 12-month price target is $447.0, a 2.83% decline from the prior average. Key analysts have adjusted their ratings and price targets.
The mixed ratings and slight decline in the average price target suggest a neutral short-term impact on Medpace Holdings' stock price. While there are more bullish ratings, the overall sentiment is tempered by the lowered price targets.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100